Flublok (Protein Sciences Corporation)
Welcome to the PulseAid listing for the Flublok drug offered from Protein Sciences Corporation. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | Protein Sciences Corporation |
NON-PROPRIETARY NAME: | Influenza Vaccine |
SUBSTANCE NAME: | INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/WISCONSIN/1/2010 REC |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2013-02-01 |
END MARKETING DATE: | 0000-00-00 |
Flublok VACCINE Details:
Item Description | Flublok from Protein Sciences Corporation |
LABELER NAME: | Protein Sciences Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 45; 45; 45(ug/.5mL; ug/.5mL; ug/.5mL) |
START MARKETING DATE: | 2013-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42874-012_e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529 |
PRODUCT NDC: | 42874-012 |
APPLICATION NUMBER: | BLA125285 |
Other INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/WISCONSIN/1/2010 REC Pharmaceutical Manufacturers / Labelers: